Percutaneous Skeletal Fixation of Painful Subchondral Bone Marrow Edema Utilizing an Injectable, Synthetic, Biocompatible Hyaluronic Acid–Based Bone Graft Substitute

Subchondral bone marrow edema (SBME) represents a pathologic alteration of subchondral bone. A strong correlation exists between its presence and the progression of osteoarthritis. Very few treatment options exist between the spectrum of conservative management and the definitive treatment of total...

Full description

Saved in:
Bibliographic Details
Published in:Arthroscopy techniques (Amsterdam) 2020-11, Vol.9 (11), p.e1645-e1650
Main Authors: Stark, Michael, DeBernardis, Dennis, McDowell, Chris, Ford, Elizabeth, McMillan, Sean
Format: Article
Language:English
Subjects:
Technical Note
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Subchondral bone marrow edema (SBME) represents a pathologic alteration of subchondral bone. A strong correlation exists between its presence and the progression of osteoarthritis. Very few treatment options exist between the spectrum of conservative management and the definitive treatment of total knee arthroplasty (TKA). Tactoset® is an injectable synthetic, biocompatible hyaluronic acid–based bone graft substitute that allows for a minimally invasive treatment for painful SBME via percutaneous skeletal fixation (PSF). We present the technique of PSF using Tactoset.
ISSN:2212-6287
2212-6287
DOI:10.1016/j.eats.2020.07.005